We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+12.21%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$53.1B
AUM Growth
+$4.7B
(+9.7%)
Cap. Flow
-$415M
Cap. Flow
% of AUM
-0.78%
Top 10 Holdings %
Top 10 Hldgs %
15.39%
Holding
2,495
New
186
Increased
937
Reduced
1,188
Closed
172
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$144M |
| 2 |
NVIDIA
NVDA
|
+$137M |
| 3 |
GE Aerospace
GE
|
+$129M |
| 4 |
Dell
DELL
|
+$91.3M |
| 5 |
Comcast
CMCSA
|
+$88.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$103M |
| 2 |
Microchip Technology
MCHP
|
+$98.3M |
| 3 |
Steel Dynamics
STLD
|
+$87M |
| 4 |
UnitedHealth
UNH
|
+$79.5M |
| 5 |
Walmart Inc
WMT
|
+$79.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.58% |
| 2 | Consumer Discretionary | 13.58% |
| 3 | Healthcare | 12.97% |
| 4 | Financials | 12.15% |
| 5 | Industrials | 12.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
Green Plains
GPRE
$1.06B
| $360K | ﹤0.01% |
14,274
+5,852
| +69% | +$155K |
|
|
DEA
2002
Easterly Government Properties
DEA
$1.13B
| $360K | ﹤0.01% |
10,700
+4,833
| +82% | +$143K |
|
2003
Sutro Biopharma
STRO
$423M
| $359K | ﹤0.01% |
8,363
+5,987
| +252% | +$190K |
|
|
CIM
2004
Chimera Investment
CIM
$980M
| $358K | ﹤0.01% |
23,892
+1,298
| +6% | +$19.6K |
|
|
B
2005
DELISTED
Barnes Group Inc.
B
| $358K | ﹤0.01% |
10,960
-9,937
| -48% | -$284K |
|
2006
AnaptysBio
ANAB
$1.64B
| $357K | ﹤0.01% |
+16,682
| New | +$288K |
|
2007
ESCO Technologies
ESE
$7.79B
| $357K | ﹤0.01% |
3,051
+602
| +25% | +$63.3K |
|
2008
First Financial Bankshares
FFIN
$4.93B
| $357K | ﹤0.01% |
11,771
-11,657
| -50% | -$309K |
|
2009
Coastal Financial
CCB
$743M
| $356K | ﹤0.01% |
8,023
-192
| -2% | -$7.93K |
|
|
ENFN
2010
DELISTED
Enfusion, Inc.
ENFN
| $356K | ﹤0.01% |
36,718
-47,692
| -57% | -$445K |
|
2011
Cohen & Steers
CNS
$4.22B
| $356K | ﹤0.01% |
4,702
-741
| -14% | -$44.6K |
|
2012
Steven Madden
SHOO
$3.58B
| $356K | ﹤0.01% |
8,468
-6,617
| -44% | -$240K |
|
2013
Matthews International
MATW
$717M
| $353K | ﹤0.01% |
9,630
-215
| -2% | -$7.88K |
|
|
HAYN
2014
DELISTED
Haynes International, Inc.
HAYN
| $352K | ﹤0.01% |
6,177
-2,567
| -29% | -$124K |
|
2015
Warby Parker
WRBY
$3.26B
| $351K | ﹤0.01% |
+24,873
| New | +$310K |
|
|
PBPB
2016
DELISTED
Potbelly
PBPB
| $348K | ﹤0.01% |
33,403
+12,286
| +58% | +$112K |
|
|
AGNT
2017
AGNT Inc
AGNT
$715M
| $347K | ﹤0.01% |
22,342
+8,147
| +57% | +$114K |
|
2018
HEICO Corp Class A
HEI.A
$37B
| $344K | ﹤0.01% |
2,417
-881
| -27% | -$119K |
|
2019
AstraZeneca
AZN
$251B
| $344K | ﹤0.01% |
2,552
+182
| +8% | +$23.7K |
|
2020
Amylyx Pharmaceuticals
AMLX
$2.53B
| $344K | ﹤0.01% |
23,344
-295
| -1% | -$4.52K |
|
|
PKST
2021
DELISTED
Peakstone Realty Trust
PKST
| $343K | ﹤0.01% |
+17,189
| New | +$280K |
|
2022
Commercial Vehicle Group
CVGI
$134M
| $343K | ﹤0.01% |
48,864
+28,591
| +141% | +$194K |
|
2023
Central Garden & Pet Co Class A
CENTA
$2.39B
| $342K | ﹤0.01% |
9,709
-2,892
| -23% | -$92.7K |
|
2024
RB Global
RBA
$17.4B
| $341K | ﹤0.01% |
5,101
+406
| +9% | +$26.1K |
|
2025
Cass Information Systems
CASS
$734M
| $341K | ﹤0.01% |
7,559
-9,179
| -55% | -$371K |
|
Similar funds
VGA
AQR Capital Management's Q4 2023 Portfolio in Review
As of Q4 2023, AQR Capital Management held 2,495 positions worth $53.1B, up 9.7% from $48.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
AQR Capital Management's Q4 2023 filing shows 186 new, 937 increased, 1,188 reduced and 172 closed positions. Its largest new stake was NCR Atleos: 518,383 shares worth $12.5M. The largest sale was Pfizer, an estimated $103M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- AQR Capital Management's largest Q4 2023 buy was NCR Atleos: 518,383 shares worth $12.5M.
- AQR Capital Management added most to Amazon in Q4 2023, an estimated $144M increase.
- AQR Capital Management's biggest Q4 2023 reduction was Pfizer, cutting an estimated $103M.
- AQR Capital Management fully exited Activision Blizzard in Q4 2023, selling an estimated $38.5M.
- AQR Capital Management's ten largest holdings make up 15% of its $53.1B portfolio in Q4 2023.
- AQR Capital Management opened 186 new positions and closed 172 in Q4 2023.
- AQR Capital Management's portfolio value rose 9.7% quarter-over-quarter to $53.1B.
Based on AQR Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.